Genedrive says Matthew Fowler has agreed to become the company's chief financial officer and a director. His formal start date will be announced shortly.
The company also says that John Rylands has decided to stand down as financial director at the conclusion of the 2016 annual general meeting. He has served as a director of the company since March 2002 and will work with the company to ensure an orderly transition.
Fowler joins Genedrive with over 15 years of experience in senior positions in the manufacturing, power and support services industries.
Chief executive David Budd said: "I am delighted to welcome Matthew to Genedrive. His recent experience in an AIM-quoted manufacturing business will no doubt be hugely valuable to Genedrive as we continue to mature as a commercial-stage near patient molecular diagnostics business.
"I would like to reiterate the board's thanks to John Rylands for his commitment and contribution to the company over the last 14 years, covering the period leading up to the company's listing on AIM and thereafter. I would also thank John for his assistance to me since I joined the company in March, this year. The board wishes him every success in the future."
Genedrive also announced it will release its preliminary results for the twelve months ending 30 June on 11 October.
At 8:14am: (LON:GDR) Genedrive Plc Ord 1.5p share price was -2.5p at 60p